Xiaoyi (Louisa) CAO
About Xiaoyi (Louisa) CAO
Xiaoyi (Louisa) Cao is an Associate Scientist in Upstream Biologics at Bristol Myers Squibb in the Greater New York City Area, with a background in biomedical engineering and extensive experience in various research and operational roles.
Current Position at Bristol Myers Squibb
Xiaoyi (Louisa) CAO currently works as an Associate Scientist in Upstream Biologics at Bristol Myers Squibb, located in the Greater New York City Area. Her role involves authoring manufacturing batch records, SOPs, and material specifications. She leads manufacturing investigations, ensures timely completion of communications, and actively identifies and implements corrective actions to ensure process integrity.
Previous Experience at Legend Biotech
Prior to her role at Bristol Myers Squibb, Xiaoyi (Louisa) CAO worked as an Operations Associate at Legend Biotech from 2019 to 2021 in the Greater New York City Area. Her stint at Legend Biotech spanned two years, contributing to different operational facets within the company.
Educational Background
Xiaoyi (Louisa) CAO holds a Bachelor of Science (BS) degree in Biomedical/Medical Engineering from the University of Rochester, which she obtained over five years from 2014 to 2019. She also attended Forest Hills High School, where she studied Health Professions and Related Programs for three years, from 2011 to 2014.
Previous Roles and Internships
Xiaoyi (Louisa) CAO has diverse experience in several roles before joining Bristol Myers Squibb. She served as a Design Engineer at the University of Rochester Medical Center and as a Research Intern at the Hospital for Special Surgery between 2018 and 2019. Additionally, she was engaged in various capacities at Sigma Psi Zeta Sorority, Inc., including Secretary, Academic Chair, and Philanthropy Chair, from 2016 to 2019 in Rochester, New York Area.
Professional Development and Contributions
During her tenure at Bristol Myers Squibb, Xiaoyi (Louisa) CAO has been involved in significant initiatives. These include participating in technology transfers from Biologics Development and external partners, supporting routine data trending, and authoring technical reports to meet regulatory and compliance requirements. She is also dedicated to pursuing technical improvement projects and implementing changes through the global change control process.